Maternal Serum FDP and Circulating Fetal Red Cells throughout Pregnancy. A Longitudinal Study

Summary

The presence of fetal red cells in the maternal circulation and the serum FDP content of 73 women was followed serially throughout a normal pregnancy. There was a significant increase in the mean serum FDP levels in late pregnancy, which was due to episodic elevations occurring in approximately 65% of women. These transient elevations appeared to increase in frequency and severity as pregnancy progressed. There was also an increase in the number of occasions fetal red cells were detected in the maternal circulation in the later months of pregnancy, but this phenomenon did not appear to be associated in any way to the serum FDP elevations. It is concluded that the episodic rises in serum FDP occurring in normal pregnancy are not related to episodes of occult disseminated intravascular coagulation secondary to placental haemorrhage as was previously hypothesized. Their etiology and clinical significance remain unknown.

• References

• 1 Bonnar J, Davidson J. F, Pidgeon C. F, McNicol G. P, and Douglas A. S. 1969; Fibrin degradation products in normal and abnormal pregnancy and parturition. British Medical Journal 3: 137.
• 2 Bonnar J, McNicol G. P, and Douglas A. S. 1971; Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. British Medical Journal 2: 12.
• 3 Brown C. J, and Stalker A. L. 1968. Proceeding of the International Conference on Microcirculation. Gothenburg, Sweden:
• 4 Burnstein R, Burns A. W, Frankel S, and Blumenthal H. T. 1965; The recurrent of an immunopathologic vascular lesion in normal and abnormal pregnancies. American Journal of Obstetrics and Gynaecology 92: 78.
• 5 Cohen F, Zuelzer W. W, Gustafson D. C, and Evans M. M. 1964; Mechanisms of iso immunisation. I. The transplacental passage of fetal erythrocytes in homospecific pregnancies. Blood 23: 621.
• 6 Das P. C. 1970; Investigation and preparation of fibrinogen coated tanned sheep red cells. Journal of Clinical Pathology 23: 149.
• 7 Devi B, Jennison B. F, and Langley F. A. 1968; Significance of placental pathology in transplacental haemorrhage. Journal of Clinical Pathology 21: 322.
• 8 Hoq M. S, and Das P. C. 1971; Preparation of human cells for the assay of serum fibrinogen degradation products using haemagglutination inhibition. Scandinavian Journal of Haematology Suppl. 13: 101.
• 9 Kleihauer E, Braun H, and Betke K. 1957; Demonstration von fetalem hämo-globin in den erythrocyten eines blutausstrichs. Klinische Wochenschrift 35: 637.
• 10 MacKay A. V. P, Das P. C, Myerscough P. R, and Cash J. D. 1967; Fibrinolytic components of human uterine arterial and venous blood. Journal of Clinical Pathology 20: 227.
• 11 Manning F. A, Wodzicki A, Dunbar L, and Coopland A. T. 1971; The fibrinolytic system in late pregnancy, labor and the early puerperium. American Journal of Obstetrics and Gynaecology 110: 900.
• 12 McKay D. G. 1972; Hematologic evidence of disseminated intravascular coagulation in eclampsia. Obstetric and Gynaecology Survey 27: 399.
• 13 Merskey C, Johnson A. J, and Lalezari P. J. 1972; Increase of fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. Journal of Clinical Investigation 51: 903.
• 14 Robinson M, Jakobowicz R, Williams L, Silberman F, and Parkinson C. 1969; The relationship of transplacental haemorrhage to rhesus immunisation. Australian and New Zealand Journal of Obstetrics and Gynaecology 9: 232.
• 15 Starkie C. M, Harding L. K, Fletcher D. J, and Stuart J. 1971; Intravascular coagulation and abnormal lung scans in pre-eclampsia and eclampsia. Lancet 2: 889.
• 16 Stiehm E. R, Kennan A. L, and Schelble D. T. 1970; Split products of fibrin in maternal serum in the perinatal period. American Journal of Obstetrics and Gynaecology 108: 941.
• 17 Walknowska J, Conte F. A, and Grumback M. M. 1969; Practical and theoretical implications of fetal/maternal lymphocyte transfer. Lancet 1: 1119.
• 18 Woodfield D. G, Cole S. K, Allan A. G. E, and Cash J. D. 1968; Serum fibrin degradation products throughout normal pregnancy. British Medical Journal 4: 665.
• 19 Woodrow J. C, and Finn R. 1966; Transplacental haemorrhage. British Journal of Haematology 12: 297.